Page 8 - Pharmascience Inc News Today

MONTREAL, Jan. 23, 2021 /CNW/ - Today the Montreal Heart Institute (MHI) announced an important step in the fight against the COVID-19 pandemic, by making ...

Article content MONTREAL, Jan. 22, 2021 (GLOBE NEWSWIRE) — The Montreal Heart Institute (MHI) announced today that the COLCORONA clinical trial has provided clinically persuasive results of colchicine’s efficacy to treat COVID-19. The study results have shown that colchicine has reduced by 21% the risk of death or hospitalizations in patients with COVID-19 compared to placebo. This result obtained for the global study population of 4488 patients approached statistical significance. The anal...

Carcinoid Tumor Market Growth 2021 | Worldwide Overview By Top Vendors, Demand, Technology Trends, Regional Outlook, Statistics Data and Forecast

Struck out on finding the perfect job? You might not have your eyes set on the right place. Now you’re in luck, Canada’s Top 100 Employers for Young People has released its 2021 list. This past year has undoubtedly been difficult, especially for young graduates who were more than eager to kickstart their careers. Though hardships faced by the pandemic are understandable, Canadian employers are making more of an effort to help students and graduates at this time. “Connecting and having op...

Benuvia Manufacturing Institutes Senior Advisory Board Valeria Coscia, Ph.D. , Bill DuBay, Ph.D., Paul Evans, and Mike Wittmann, Ph.D. will strategically advise Benuvia Manufacturing, a growing, privately held company News provided by Share this article Share this article ROUND ROCK, Texas, Jan. 14, 2021 /PRNewswire/ -- Benuvia Manufacturing, Inc, a leading CDMO providing small molecule active pharmaceutical ingredients, formulation and drug product manufacturing from preclinical to commercia...

  WINNIPEG -- Pharmascience Inc. is recalling 13 lots of its store-brand 75 mg ranitidine products after tests found above-average levels of NDMA, a probable human carcinogen. Ranitidine is used in over the counter products to prevent and treat heartburn associated with acid indigestion and sour stomach. In September 2019, Health Canada directed companies to stop distributing ranitidine products because tests were showing the presence of the NDMA impurity. The organization has since allowe...